United States of America v. Wagoner

CourtDistrict Court, N.D. Indiana
DecidedMarch 31, 2021
Docket2:17-cv-00478
StatusUnknown

This text of United States of America v. Wagoner (United States of America v. Wagoner) is published on Counsel Stack Legal Research, covering District Court, N.D. Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America v. Wagoner, (N.D. Ind. 2021).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF INDIANA HAMMOND DIVISION

UNITED STATES OF AMERICA and THE STATE OF INDIANA,

Plaintiffs,

v. CAUSE NO. 2:17-CV-478-TLS-JEM

DON J. WAGONER and WAGONER MEDICAL CENTER, L.L.C.,

Defendants.

OPINION AND ORDER This matter is before the Court on the Defendants’ Rule 72(a) Objection to Order Denying Motion for Reconsideration [ECF No. 61]. The Defendants seek review under Federal Rule of Civil Procedure 72(a) of the October 22, 2019, Opinion and Order denying the Defendants’ Motion to Reconsider Court’s Order Granting the Plaintiffs’ Leave to Amend the Complaint [ECF No. 54]. The Plaintiffs filed a Memorandum In Opposition [ECF No. 65]. For the reasons set forth below, the Court OVERRULES the Defendants’ Objection, and ACCEPTS the Third Amended Complaint. BACKGROUND This case raises various claims related to an alleged scheme run by the Defendants to defraud Medicaid. The Plaintiffs filed their original Complaint December 29, 2017 [ECF No. 1]. On December 13, 2018, the Court set June 10, 2019, as the deadline for the Plaintiffs to file any Motion to Amend the pleadings and July 10, 2019, as the deadline for the Defendants [ECF No. 34]. The Plaintiffs filed the first Amended Complaint on January 18, 2019 [ECF No. 38]. On July 10, 2019, the Plaintiffs moved to file a Second Amended Complaint [ECF No. 43].1 The Motion explained that the Plaintiffs discovered that the Medicaid claims for urine drug screen tests were false and fraudulent for an additional, as-yet-unpled reason: the screens were not used for patient care and thus lacked any medical necessity. Mot. for Leave to File the Second Am. Compl. and Jury Demand of Pls. United States of America and State of Indiana ¶ 1,

ECF No. 43. The Motion did not argue any particular standard but noted that the expert disclosures explained in detail the basis for the “additional, clarifying allegations” in the Second Amended Complaint. Id. at 3. The Defendants opposed the Plaintiff’s Motion [ECF No. 44]. The Defendants argued that the Plaintiffs had failed to establish good cause under Rule 16(b)(4), because the new theory of the case was based on an expert whose qualifications the Defendants challenged,2 and whom the Defendants argued the Plaintiffs had selected specifically to develop this new theory, describing it as “bought-and-paid for.” Defs.’ Resp. Objecting to Pls.’ Mot. for Leave to File a Second Am. Compl. 11, ECF No. 44. The Defendants also argued that the evidence had been in

the Plaintiffs’ possession for nearly seven years and was thus not newly discovered. Id. at 10. The Plaintiffs replied, arguing under Rule 16(b)(4) that their Motion met the standard as only the expert’s review allowed them to draft the proposed Second Amended Complaint. Pls.’

1 Subsequent to all the briefing on the Motion for Leave to File the Second Amended Complaint and Motion to Reconsider, the parties by agreement filed a Third Amended Complaint that addressed a separate issue. See Joint Mot. of All Parties Regarding Discovery and for Leave for Pls. to File a Third Am. Compl., ECF No. 81; Jan. 15, 2020 Order, ECF No. 82. However, the Defendants did not waive “any previous objections.” Joint Mot. 2 ¶ 3. Therefore, the Defendants’ Rule 72(a) Objection to the Second Amended Complaint remained pending. However, because the Court is overruling the Defendant’s objection in this Opinion, the Third Amended Complaint will be the operative complaint.

2 Eventually the Defendants filed their Motion to Exclude Testimony Regarding Clinical Appropriateness [ECF No. 59], challenging the new expert report under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharms. Inc., 509 U.S. 579 (1993). However, that Motion was not filed until October 31, 2019, and was not on the record at any point during the events described. Reply Mem. in Support of the Mot. for Leave to File 8–9, ECF No. 45. Specifically, the Plaintiffs identified an expert’s report, generated on June 28, 2019, as the source of the new theory; until they had the report, they could not have drafted the proposed Second Amended Complaint; thus, despite their diligence, the Plaintiffs needed a modification of the Court’s scheduling order to amend the pleadings after their June 10, 2019 deadline. Id. In explaining why

their initial motion did not request the necessary modification of the scheduling order, the Plaintiffs explained that they had inadvertently mis-calendared the due date as July 10, 2019, the Defendants’ deadline, thus failing to move for an extension in their first Motion for Leave—but noting that they would have done so. Id. at 9 n.10. On September 12, 2019, the Magistrate Judge granted the Motion for Leave to Amend. See Sept. 12, 2019 Order 4, ECF No. 46. The Order held that (1) the Plaintiffs acted diligently such that good cause for modifying the order was shown, as required by Rules 16(b)(4) and (6)(b)(1); (2) the failure to request an extension before the deadline was due to excusable neglect, so the Magistrate Judge declined to deny the Motion for untimeliness, pursuant to

Rule 6(b)(1)(B); and (3) under Rule 15(a)(2) and its associated case law, no bad faith or undue prejudice applied, and thus leave to amend was appropriate. On September 26, 2019, the Defendants filed a Motion to Reconsider Court’s Order Granting Plaintiffs’ Leave to Amend the Complaint [ECF No. 51]. The Defendants made three arguments. First, the Defendants expanded their previous argument that the evidence was not newly acquired, emphasizing that (i) the criminal case, to which the Plaintiff State of Indiana was a party, contained the same information and (ii) the subpoena for the records on which the new expert report is based was issued four months earlier. Defs.’ Mot. to Reconsider 2–3, ECF No. 51. Second, the Defendants also challenged the Plaintiffs’ failure to move to extend the scheduling deadline; specifically, the Defendants pointed out that “failing to calendar the deadline is not sufficient to show excusable neglect.” Id. at 6 (citing Naudv v. City of Rockford, No. 09 cv 50074, 2013 WL 4447028, at *5 (N.D. Ill. Aug. 16, 2013) (citing Lapsley v. Fries, 1:11‐cv‐99, 2012 WL 2721909 (N.D. Ind. July 9, 2012) (no excusable neglect where counsel mis-calendared discovery deadline)). Third, the Defendants contend the Magistrate Judge applied

the wrong standard in reaching his conclusion. The Defendants, citing the September 12, 2019, Order, argued the Magistrate Judge applied the Rule 15(a)(2) bad faith and undue prejudice analysis instead of the Rule 16(b) analysis. Id. at 6–7. The Plaintiffs responded. See Mem. of Pls.’ United States of America and State of Indiana in Opp. to Defs.’ Mot. to Reconsider, ECF No. 52. As relevant, the Plaintiffs argued that (1) they did not know the expert had reviewed medical records in the criminal case until “a few days before” receiving his expert report; and (2) having the medical records does not mean the Plaintiffs knew the information the expert recently provided because an expert was required for the theory to take shape. Id. at 5. Next, the Plaintiffs addressed the timing of their Motion for

Leave to Amend. Citing Tschantz v. McCann, 160 F.R.D. 568 (N.D. Ind. 1995), the Plaintiffs articulated that they could not have filed their motion any earlier and thus argued that they had satisfied good cause.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Murphy v. EDDIE MURPHY PRODUCTIONS, INC.
611 F.3d 322 (Seventh Circuit, 2010)
Alioto v. Town of Lisbon
651 F.3d 715 (Seventh Circuit, 2011)
Bret Broaddus v. Kevin Shields
665 F.3d 846 (Seventh Circuit, 2011)
Hicks v. Midwest Transit, Inc.
531 F.3d 467 (Seventh Circuit, 2008)
Anthony Hill v. Daniel M. Tangherlini
724 F.3d 965 (Seventh Circuit, 2013)
Davis v. Carmel Clay Schools
286 F.R.D. 411 (S.D. Indiana, 2012)
Tschantz v. McCann
160 F.R.D. 568 (N.D. Indiana, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
United States of America v. Wagoner, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-v-wagoner-innd-2021.